Back to SYRE

B Group, Inc. → SYRE

B Group, Inc. SYRE Position History

Spyre Therapeutics, Inc. • Healthcare

Quarters held
4
Latest value
$5.6M
Q3 2026
Peak value
$6.2M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$3.3M
Q1 2026$5M
Q2 2026$6.2M
Q3 2026$5.6M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$5.6M62.5K——
Q2 2026$6.2M70.0K——
Q1 2026$5M100.0K——
Q4 2025$3.3M100.0K——

Other funds holding SYRE

Other B Group, Inc. positions

ADMA

ADMA BIOLOGICS INC

$44.8M
ADMA

ADMA BIOLOGICS INC

$32.7M
ADMA

ADMA BIOLOGICS INC

$28.9M
ADMA

ADMA BIOLOGICS INC

$27.3M
FTH

FAETH THERAPEUTICS INC

$18.1M
CLLS

CELLECTIS S A

$15.9M
FTH

FAETH THERAPEUTICS INC

$15.3M
TSHA

TAYSHA GENE THERAPIES INC

$12.3M